Lexogen
Lexogen | RNA-Seq sample prep | RNA-Seq Data Analysis Software | RNA Spike-in Controls.
Financials
Estimates*
EUR | 2016 | 2021 | 2022 |
---|---|---|---|
Revenues | 2.9m | - | - |
Profit | - | (4.0m) | (3.3m) |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
€160k | Grant | ||
N/A | Grant | ||
Total Funding | €160k |
Related Content
Recent News about Lexogen
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.